Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$20.78 - $31.77 $1.18 Million - $1.81 Million
57,000 New
57,000 $1.79 Million
Q1 2021

May 13, 2021

SELL
$25.02 - $54.99 $1.16 Million - $2.55 Million
-46,300 Reduced 98.93%
500 $13,000
Q1 2020

May 13, 2020

SELL
$31.65 - $46.87 $1.06 Million - $1.57 Million
-33,400 Reduced 41.65%
46,800 $1.98 Million
Q4 2019

Feb 10, 2020

BUY
$36.21 - $51.4 $1.21 Million - $1.71 Million
33,300 Added 71.0%
80,200 $3.43 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $6.81 Million - $13.5 Million
-306,300 Reduced 86.72%
46,900 $1.69 Million
Q2 2019

Aug 14, 2019

BUY
$23.32 - $28.12 $4.41 Million - $5.32 Million
189,200 Added 115.37%
353,200 $9.44 Million
Q1 2019

May 15, 2019

SELL
$16.17 - $27.38 $3.48 Million - $5.9 Million
-215,500 Reduced 56.79%
164,000 $4.4 Million
Q4 2018

Feb 14, 2019

SELL
$14.32 - $22.92 $4.17 Million - $6.67 Million
-291,000 Reduced 43.4%
379,500 $6.14 Million
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $6.73 Million - $11.3 Million
516,600 Added 335.67%
670,500 $13.9 Million
Q2 2018

Aug 14, 2018

BUY
$15.07 - $22.34 $620,884 - $920,408
41,200 Added 36.56%
153,900 $2.35 Million
Q1 2018

May 15, 2018

BUY
$22.47 - $32.33 $422,436 - $607,804
18,800 Added 20.02%
112,700 $2.53 Million
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $2.18 Million - $3.18 Million
-81,200 Reduced 46.37%
93,900 $2.83 Million
Q3 2017

Nov 14, 2017

BUY
$29.49 - $38.37 $5.16 Million - $6.72 Million
175,100
175,100 $6.6 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.